Types | HSIL | LSIL | Normal | Total |
|---|
n | % | n | % | n | % | n | % |
|---|
Total | 1745 | | 1354 | | 35 | | 3134 | |
Total HPV (+) | 1640 | 93.98% | 1195 | 88.26% | 20 | 57.14% | 2803 | 89.44% |
HPV6,11 | 36 | 2.20% | 64 | 5.36% | 4 | 20.00% | 104 | 3.71% |
HPV16 | 926 | 56.46% | 289 | 24.18% | 8 | 40.00% | 1223 | 43.63% |
HPV18 | 120 | 7.32% | 132 | 11.05% | | | 252 | 8.99% |
HPV21 | 38 | 2.32% | 14 | 1.17% | | | 52 | 1.86% |
HPV31 | 135 | 8.23% | 56 | 4.69% | 5 | 25.00% | 196 | 6.99% |
HPV33 | 123 | 7.50% | 45 | 3.77% | 1 | 5.00% | 169 | 6.03% |
HPV35 | 53 | 3.23% | 57 | 4.77% | 1 | 5.00% | 111 | 3.96% |
HPV39 | 70 | 4.27% | 128 | 10.71% | | | 198 | 7.06% |
HPV45 | 36 | 2.20% | 26 | 2.18% | 2 | 10.00% | 64 | 2.28% |
HPV51 | 126 | 7.68% | 156 | 13.05% | 1 | 5.00% | 283 | 10.10% |
HPV52 | 266 | 16.22% | 263 | 22.01% | 3 | 15.00% | 532 | 18.98% |
HPV56 | 102 | 6.22% | 170 | 14.23% | 1 | 5.00% | 273 | 9.74% |
HPV58 | 302 | 18.41% | 255 | 21.34% | 3 | 15.00% | 560 | 19.98% |
HPV59 | 71 | 4.33% | 68 | 5.69% | 2 | 10.00% | 141 | 5.03% |
HPV66 | 40 | 2.44% | 71 | 5.94% | 3 | 15.00% | 114 | 4.07% |
HPV67 | 22 | 1.34% | 7 | 0.59% | 2 | 10.00% | | |
HPV68 | 34 | 2.07% | 87 | 7.28% | 1 | 5.00% | 122 | 4.35% |
HPV82 | 27 | 1.65% | 22 | 1.84% | | | 49 | 1.75% |
- The proportion of HPV16 type in HSIL was significantly different from that of other high-risk type HPV, P < 0.05 (HPV58, χ2 = 30.97; HPV52, χ2 = 34.72; HPV31, χ2 = 52.94; HPV51, χ2 = 52.94)
- The proportion of HPV58 type in HSIL was significantly different from that of other high-risk type HPV, p < 0.05 (HPV16, χ2 = 30.97; HPV31, χ2 = 4.42; HPV51, χ2 = 4.42) except for HPV52, χ2 = 0.14, p = 0.71 > 0.05
- The proportion of HPV52 type in HSIL was significantly different from that of HPV16, χ2 = 34.72, p < 0.05 except for HPV58, χ2 = 0.14, p = 0.71 > 0.05; HPV31, χ2 = 3.03, p = 0.08 > 0.05; HPV51, χ2 = 3.03, p = 0.08 > 0.05
- The proportion of HPV16 type in LSIL was significantly different from that of HPV51, χ2 = 4.01, p = 0.045 < 0.05 except for HPV52, χ2 = 0.11, p = 0.72 > 0.05; HPV58, χ2 = 0.26, p = 0.611 > 0.05; HPV56, χ2 = 3.25, p = 0.071 > 0.05
- The proportion of HPV52 type in LSIL was not significantly different from that of following HPV type, P > 0.05 (HPV16, χ2 = 0.11, p = 0. 72; HPV58, χ2 = 0.03, p = 0.86; HPV56, χ2 = 2.17, p = 0.14; HPV51, χ2 = 2.91, p = 0.088
- The proportion of HPV58 type in LSIL was not significantly different from that of following HPV type, P > 0.05 (HPV58, χ2 = 0.26, p = 0.61; HPV52, χ2 = 0.03, p = 0.86; HPV56, χ2 = 1.70, p = 0.19; HPV51, χ2 = 2.27, p = 0.13
- The proportion of HPV16 type in normal cervical lesion was significantly different from that of following HPV type, P < 0.05 (HPV31, χ2 = 5.13, p = 0.024; HPV6,11,52,58,66, Fisher test, p < 0.0001;)
- The proportion of HPV31 type in normal cervical lesion was significantly different from HPV16, χ2 = 5.13, p = 0.024 < 0.05; except for HPV6,11,52,58,66 (Fisher test, p = 0.111 > 0.05
